☆ 4.6 Article

The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE's New Methods Manual

VALUE IN HEALTH (2023)

Related references

Note: Only part of the references are listed.

Letter Biochemistry & Molecular Biology

The success of NHS England's Innovative Medicines Fund will depend on its operational details

Aris Angelis et al.

NATURE MEDICINE (2023)

Add to Collection

Article Economics

Modifying NICE's Approach to Equity Weighting

Mike Paulden et al.

Summary: NICE recently launched a consultation on the role of equity weights in evaluating new health technologies and concluded that the current approach reduces both population health and equity-weighted population health. The paper suggests adopting a standard 'net benefit' approach for increased transparency and lower effective cost-effectiveness thresholds for evaluating certain new technologies. This poses a challenge for NICE in light of its obligations under the 2019 'Voluntary Scheme'.

PHARMACOECONOMICS (2021)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries

Cassandra Nemzoff et al.

BMJ GLOBAL HEALTH (2021)

Add to Collection

Review Economics

Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics

Liz Morrell et al.

PHARMACOECONOMICS (2017)

Add to Collection

Review Oncology

Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund

A. Aggarwal et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Editorial Material Medicine, General & Internal

Cancer Drugs Fund requires further reform

Richard Grieve et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Add to Collection

Editorial Material Medicine, General & Internal

Cancer Drugs Fund requires further reform

Richard Grieve et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Add to Collection

Article Health Care Sciences & Services

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

Karl Claxton et al.

HEALTH TECHNOLOGY ASSESSMENT (2015)

Add to Collection

Review Public, Environmental & Occupational Health

Attributes and weights in health care priority setting: A systematic review of what counts and to what extent

Yuanyuan Gu et al.

SOCIAL SCIENCE & MEDICINE (2015)

Add to Collection

Article Health Care Sciences & Services

USE OF VALUE OF INFORMATION IN UK HEALTH TECHNOLOGY ASSESSMENTS

Syed Mohiuddin et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2014)

Add to Collection

Article Economics

SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE-BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS-SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN

Warren G. Linley et al.

HEALTH ECONOMICS (2013)

Add to Collection

Article Economics

Comparative Effectiveness, Personalized Medicine and Innovation The Path Forward

Adrian Thomas et al.

PHARMACOECONOMICS (2010)

Add to Collection

Article Economics

The Value of Value of Information Best Informing Research Design and Prioritization Using Current Methods

Simon Eckermann et al.

PHARMACOECONOMICS (2010)

Add to Collection

Article Health Policy & Services

Evidence-informed evidence-making

Kalipso Chalkidou et al.

JOURNAL OF HEALTH SERVICES RESEARCH & POLICY (2008)

Add to Collection

Article Economics

Expected value of information and decision making in HTA

Simon Eckermann et al.

HEALTH ECONOMICS (2007)

Add to Collection

Article Economics

Using value of information analysis to prioritise health research - Some lessons from recent UK experience

Karl P. Claxton et al.

PHARMACOECONOMICS (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.